Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis

Johns Hopkins laryngologist Simon Best outlines a new treatment option for patients with recurrent respiratory papillomatosis, a chronic HPV disease that has traditionally required repeated surgical interventions. Best explains how intravenous bevacizumab can be used in lieu of surgery, and that he expects it will one day become the standard of care for this disease. Read the consensus statement at onlinelibrary.wiley.com/doi/full/10.1002/lary.31670